Company:  MEDGENICS, INC. (MDGN)
Form Type:  10-K
Filing Date:  3/6/2012 
CIK:  0001138776 
Address:  TERADION BUSINESS PK.
P.O. BOX 14 
City, State, Zip:  MISGAV,  20179 
Telephone:  1-646-239-1690 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.25   		Change: 
-0.07 (-1.62%)  
Trade Time: 
May 17   		Market Cap: 
$78.54M
Description of Business
Register for a Free Trial and access this filing in:     
  FORM 10-K
    PART I
      ITEM 1 - Business.
      ITEM 1A - Risk Factors.
      ITEM 1B - Unresolved Staff Comments.
      ITEM 2 - Properties.
      ITEM 3 - Legal Proceedings.
      ITEM 4 -Mine Safety Disclosures
    PART II
      ITEM 5 - Market for Registrant's Common Equity, Related ...
      ITEM 6 - Selected Financial Data.
      ITEM 7 - Management's Discussion and Analysis of Financial ...
        Liquidity and Capital Resources
      ITEM 7A - Quantitative and Qualitative Disclosures About ...
      ITEM 8 - Financial Statements and Supplementary Data.
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        CASH FLOW
        NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
          NOTE 13:- SUBSEQUENT EVENTS
      ITEM 9 - Changes in and Disagreements with Accountants on ...
      ITEM 9A - Controls and Procedures.
      ITEM 9B - Other Information.
    PART III
      ITEM 10 - Directors, Executive Officers and Corporate ...
      ITEM 11 - Executive Compensation.
      ITEM 12 - Security Ownership of Certain Beneficial Owners ...
      ITEM 13 - Certain Relationships and Related Transactions, ...
      ITEM 14 - Principal Accountant Fees and Services.
    PART IV
      ITEM 15 - Exhibits and Financial Statement Schedules.
    SIGNATURES
  EXHIBIT 3.3
    Second Amended and Restated By-Laws of Medgenics, Inc.
  EXHIBIT 21.1
  EXHIBIT 31.1
    CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
© 1995-2013 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement